For the quarter ending 2026-03-31, ONC made $1,513,438K in revenue. $227,357K in net income. Net profit margin of 15.02%.
| Income Statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | |
|---|---|---|---|---|
| Total revenues | 1,513,438 | 1,106,181* | 1,412,284 | |
| Cost of sales - product | 167,215 | 79,010* | 196,510 | |
| Gross profit | 1,346,223 | 1,027,171* | 1,215,774 | |
| Research and development | 541,224 | 574,766* | 523,662 | |
| Selling, general and administrative | 555,097 | 494,495* | 528,998 | |
| Total operating expenses | 1,096,321 | 1,069,261* | 1,052,660 | |
| Income from operations | 249,902 | -42,090* | 163,114 | |
| Interest income | 27,664 | 17,626* | - | |
| Interest income, net | - | - | 3,029 | |
| Interest expense | 32,887 | 14,559* | - | |
| Other income, net | 14,536 | 14,384* | -18,979 | |
| Income before income taxes | 259,215 | -24,638* | 147,164 | |
| Income tax expense | 31,858 | 62,952* | 22,323 | |
| Net income | 227,357 | -87,590 | 124,841 | |
| Basic EPS | 0.16 | -0.062 | 0.09 | |
| Diluted EPS | 0.15 | -0.06 | 0.08 | |
| Basic Average Shares | 1,442,451,870 | 1,402,805,755 | 1,432,801,699 | |
| Diluted Average Shares | 1,505,027,338 | 1,460,909,462 | 1,488,750,354 | |
BeOne Medicines Ltd. (ONC)
BeOne Medicines Ltd. (ONC)